NCT05101564 2026-02-12
Umbrella Trial of Subtype-Targeted Therapies in ER+/HER2- Breast Cancer
Stanford University
Phase 2 Completed
Stanford University
Novartis
MedSIR
Peter MacCallum Cancer Centre, Australia
Seoul National University Hospital
Novartis